Percutaneous Skeletal Fixation of Painful Subchondral Bone Marrow Edema Utilizing an Injectable, Synthetic, Biocompatible Hyaluronic Acid-Based Bone Graft Substitute.

Autor:	Stark M; Rowan School of Osteopathic Medicine, Stratford, New Jersey, U.S.A., DeBernardis D; Rowan School of Osteopathic Medicine, Stratford, New Jersey, U.S.A., McDowell C; Rowan School of Osteopathic Medicine, Stratford, New Jersey, U.S.A., Ford E; Inspira Medical Center, Vineland, New Jersey, U.S.A., McMillan S; Rowan School of Osteopathic Medicine, Stratford, New Jersey, U.S.A.; Department of Sports Medicine and Arthroscopy, Virtua Willingboro Hospital, Burlington, New Jersey, U.S.A.
Jazyk:	angličtina
Zdroj:	Arthroscopy techniques [Arthrosc Tech] 2020 Oct 22; Vol. 9 (11), pp. e1645-e1650. Date of Electronic Publication: 2020 Oct 22 (Print Publication: 2020).
DOI:	10.1016/j.eats.2020.07.005
Abstrakt:	Subchondral bone marrow edema (SBME) represents a pathologic alteration of subchondral bone. A strong correlation exists between its presence and the progression of osteoarthritis. Very few treatment options exist between the spectrum of conservative management and the definitive treatment of total knee arthroplasty (TKA). Tactoset® is an injectable synthetic, biocompatible hyaluronic acid-based bone graft substitute that allows for a minimally invasive treatment for painful SBME via percutaneous skeletal fixation (PSF). We present the technique of PSF using Tactoset. (© 2020 by the Arthroscopy Association of North America. Published by Elsevier.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu